BioCentury
ARTICLE | Clinical News

Epi proColon: Clinical trial completed enrollment

March 30, 2015 7:00 AM UTC

Epigenomics completed enrollment of about 420 average-risk patients ages 50-76 that have been historically non-compliant to colorectal cancer screening according to screening guidelines in the U.S. AD...